Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Ronot

Showing results (351-360 of 391) with videos related to

Pageof 40
Sort By:
Neuroendocrinology|July 28, 2020
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of VariabilityClarisse Dromain, Anders Sundin, Pavan Najran, et al.
The Oncologist|March 27, 2019
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET StudyAngela Lamarca, Joakim Crona, Maxime Ronot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 19, 2020
Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 PatientsAnita Paisant, Sylvain Lemoine, Christophe Cassinotto, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Improving risk stratification and detection of early HCC using ultrasound-based deep learning modelsJérémy Dana, Adrien Meyer, Anita Paisant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 StudyAngela Lamarca, Maxime Ronot, Salma Moalla, et al.
The British Journal of Surgery|February 10, 2022
Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinomaChristian Hobeika, Clémence Guyard, Riccardo Sartoris, et al.
Journal of Hepatology|September 26, 2021
Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus diseaseChloé De Broucker, Aurélie Plessier, Isabelle Ollivier-Hourmand, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 30, 2012
Effects of a multimodal management strategy for acute mesenteric ischemia on survival and intestinal failureOlivier Corcos, Yves Castier, Annie Sibert, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2024
Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF)Cindy Neuzillet, Marie Decraecker, Hélène Larrue, et al.
The Journal of Infection|August 21, 2023
Evaluation of the contribution of shotgun metagenomics in the microbiological diagnosis of liver abscessesHadrien Kimseng, Geoffrey Rossi, Maxime Danjean, et al.
Pageof 40

Showing results (351-360 of 391) with videos related to

Sort By:
Pageof 40
Neuroendocrinology|July 28, 2020
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of VariabilityClarisse Dromain, Anders Sundin, Pavan Najran, et al.
The Oncologist|March 27, 2019
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET StudyAngela Lamarca, Joakim Crona, Maxime Ronot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 19, 2020
Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 PatientsAnita Paisant, Sylvain Lemoine, Christophe Cassinotto, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Improving risk stratification and detection of early HCC using ultrasound-based deep learning modelsJérémy Dana, Adrien Meyer, Anita Paisant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 StudyAngela Lamarca, Maxime Ronot, Salma Moalla, et al.
The British Journal of Surgery|February 10, 2022
Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinomaChristian Hobeika, Clémence Guyard, Riccardo Sartoris, et al.
Journal of Hepatology|September 26, 2021
Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus diseaseChloé De Broucker, Aurélie Plessier, Isabelle Ollivier-Hourmand, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 30, 2012
Effects of a multimodal management strategy for acute mesenteric ischemia on survival and intestinal failureOlivier Corcos, Yves Castier, Annie Sibert, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2024
Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF)Cindy Neuzillet, Marie Decraecker, Hélène Larrue, et al.
The Journal of Infection|August 21, 2023
Evaluation of the contribution of shotgun metagenomics in the microbiological diagnosis of liver abscessesHadrien Kimseng, Geoffrey Rossi, Maxime Danjean, et al.
Pageof 40